Kiora Pharmaceuticals, Inc. (KPRX)
$2.56+0.79%Close
SELLBEAR · day 7
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $11M
- Beta
- -0.39
- P/E (TTM)
- -1.00
- Short % float
- 0.08%
- Days to cover
- 1.0
- SI change
- -14.6%
- 1W
- +1.19%
- 1M
- -3.40%
- vs SPY 1W
- +0.76%
- vs SPY 1M
- -5.46%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on KPRX?
- LOPJLB’s latest quantitative signal on Kiora Pharmaceuticals, Inc. (KPRX) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is KPRX in?
- Kiora Pharmaceuticals, Inc. (KPRX) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Kiora Pharmaceuticals, Inc. (KPRX) do?
- Kiora Pharmaceuticals, Inc., a specialty pharmaceutical firm operating at the clinical stage, is dedicated to the creation and commercialization of treatments for various ophthalmic conditions across the United States. Its flagship therapeutic candidate, KIO-301, is a groundbreaking small molecule undergoing Phase 1 clinical trials. This innovative "photoswitch" aims to revitalize vision in ind…